I like the sound of this one. Seems to have a lot of positives-...

I like the sound of this one. Seems to have a lot of positives-

*Proven product
*Massive market, some 1.6 billion piglets weaned globally each year, albeit only around 4 million in Australia.
*No proven competition in non antibiotic scours treatment. Can also be administered as a preventative measure.
*Cheap raw materials.
*Cheaper than traditional antibiotic treatments.
*Growing consumer demand for antibiotic free treated meat products.
*Tight capital structure, (only 14m shares on issue)
*Physiologically, pigs are very similar to humans paving the way to antibiotic free human diahorrea treatment. This market would be astronomical.

As a dairy farmer I understand the impact scours can have on intensive animal production, particularly in piggeries. If ANR can get Detach to market, surely it will do well. I picked up a few in the float, obviously disappointed so far. General market conditions haven't been in our favour so far. Let's see what unfolds.